000 | 01712cam a22003975i 4500 | ||
---|---|---|---|
999 |
_c200452309 _d70521 |
||
001 | 200452309 | ||
003 | TR-AnTOB | ||
005 | 20230526174947.0 | ||
006 | m |o d | | ||
007 | cr cnu---aauau | ||
008 | 200825s2021 mau o 000 0 eng d | ||
010 | _a 2020944932 | ||
020 |
_a9780128209189 _q(ebook) |
||
020 |
_z9780128207574 _q(paperback) |
||
040 |
_aDLC _beng _erda _cDLC _dTR-AnTOB |
||
041 | 0 | _aeng | |
042 | _apcc | ||
060 | 1 |
_aQV 744 _bP895 2021EBK |
|
096 |
_aQV 744 _bP895 2021EBK |
||
245 | 0 | 0 |
_aNanoparticle therapeutics : _bproduction technologies, types of nanoparticles, and regulatory aspects / _cPrashant Kesharwani, Kamalinder K. Singh, Rajneet Kaur Khurana, Kanchan Kohli. |
264 | 1 |
_aWaltham : _bElsevier, _c2021. |
|
300 | _a1 online resource | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
504 | _aBIBINDX | ||
520 |
_a"Brings together the novel applications of nanotechnology in biological fields Explores perspectives on technologies through highly organized tables, illustrative figures and flow charts Addresses key multidisciplinary challenges faced by nanotechnologists to foster collaboration among biologists, chemists, physicists, engineers and clinicians"-- _cProvided by publisher. |
||
650 | 2 |
_aChemistry, Pharmaceutical _956670 |
|
700 | 1 |
_aKesharwani, Prashant, _eeditor. |
|
700 | 1 |
_aSingh, Kamalinder K., _eeditor. |
|
700 | 1 |
_aKhurana, Rajneet Kaur, _eeditor. |
|
700 | 1 |
_aKohli, Kanchan, _eeditor. |
|
856 | 4 | 0 |
_3ScienceDirect _zConnect to resource _uhttps://www.sciencedirect.com/science/book/9780128207574 |
942 |
_2NLM _cEBK |